Recruiting
Mavacamten Pregnancy Surveillance Program - CV027-014
Zaktualizowano:
22 listopad, 2023
|
ClinicalTrials.gov
Płeć
Zakres wieku
Lokalizacje
Recruiting
Inclusion Criteria: - Exposure to at least 1 dose of mavacamten at any time during pregnancy (from 4 months prior to conception to pregnancy outcome) and/or at any time during breastfeeding (up to 12 months of infant age or weaning, whichever comes first) - At least 15 years of age or older at the time of enrollment - Informed consent or institutional review board/ethics committee-approved waiver of informed consent Exclusion Criteria: - None